'Population pharmacokinetics' presentation slideshows

A case example: Building a population pharmacokinetic model for theophylline using NONMEM program.

607 views • 35 slides

583 views • 28 slides

Population Pharmacokinetics

396 views • 28 slides

Mario Sampson, PharmD Duke Clinical Research Institute

Pharmacokinetics and Safety of Metronidazole in Preterm Infants: Validation of Dried Blood Spot Sampling. Mario Sampson, PharmD Duke Clinical Research Institute University of North Carolina Eshelman School of Pharmacy. Background. In preterm infants, intra-abdominal infections are deadly

337 views • 10 slides

Mario Sampson, PharmD Duke Clinical Research Institute

Pharmacokinetics and Safety of Metronidazole in Preterm Infants: Validation of Dried Blood Spot Sampling. Mario Sampson, PharmD Duke Clinical Research Institute University of North Carolina Eshelman School of Pharmacy. Background.

319 views • 10 slides

Working Group on Pharmacokinetics and Population Pharmacokinetics

Working Group on Pharmacokinetics and Population Pharmacokinetics. Alfonso Iorio, MD, PhD, Professor of Medicine Department of Health Research Methods, Evidence, and Impact McMaster University, Canada. Acknowledgements. Core working group. Extended working group. David Lillicrap

84 views • 7 slides

POPULATION PHARMACOKINETICS OF CEFTRIAXONE IN INTENSIVE CARE UNIT (ICU) ADULT PATIENTS

CL=THETA(1)+THETA(2)*(CLcr/4.26) THETA (1)=0.56; rse=19.6 THETA(2)= 0.32; rse=37.5. POPULATION PHARMACOKINETICS OF CEFTRIAXONE IN INTENSIVE CARE UNIT (ICU) ADULT PATIENTS C Le Guellec (1), N Simon (2), D.Garot (3), R. Respaud (1), P Lanotte (4), H. Blasco (1), PF Dequin (3).

216 views • 1 slides